Top Ten most popular articles on Pharmafile.com this week
pharmafile | July 24, 2020 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, coronavirus, top 10, top 10 stories
As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it, while health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be ineffective.
In non-coronavirus related news, the FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs.
1. Israeli doctor tests positive for coronavirus 3 months after recovering
An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it.
2. UK secures early access to 90 million doses of coronavirus vaccines
The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.
3. Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company has just revealed promising data on the interferon beta-based therapy, known as SNG001, in the treatment of patients hospitalised with the disease.
Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be ineffective.
5. Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India
Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with COVID-19 under the brand name Desrem, it has emerged.
6. Hydroxychloroquine proves ineffective against COVID-19 in newest trial
The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients.
7. Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait
Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait.
8. FDA sets out guidelines on cannabis derived drugs
The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs.
9. Study launched to assess if asthma treatment ciclesonide can treat COVID-19
Researchers at the University of Buffalo have launched a study to see if the steroid treatment ciclesonide could be effective in treating the coronavirus.
There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according to a cross-party group of MPs.
Conor Kavanagh
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
